Try Alerts Free   |   Login
Health Care › In Vitro And In Vivo Diagnostic Substances

NEOG Price Correlated With Financials For Neogen

Free historical financial statements for Neogen Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 44 quarters since 2011. Compare with NEOG stock chart to see long term trends.

NEOG Stock Compared to Quarterly

NEOG Income Statement

Revenue, Net:140093000
Revenue Per Share:1.2991
Cost of Goods & Services Sold:75094000
Gross Profit:64999000
Selling, General & Admin Expense:17864000
Research & Development Expense:3831000
Total Operating Expenses:46972000
Operating Income:18891000
Income Taxes:9292000
Net Income:14959000
Earnings Per Share, Basic:0.14
Shares Outstanding, Basic Avg:107837730

NEOG Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:5861000
Change in Accounts Receiveable:6915000
Net Cash from Operations:20390000
Net Cash from Operations Per Share:0.1891
Net Cash from Financing Activities:-1029000
Property, Plant & Equipment Purchases:12538000
Net Cash from Investing Activities:-17099000
Net Change in Cash & Equivalents:1594000

NEOG Balance Sheet

Cash and Cash Equivalents:44473000
Short-Term Investments:336578000
Accounts Receivable, Net:99674000
Inventories:122313000
Total Current Assets:626798000
Property, Plant & Equipment, Net:110584000
Total Assets:992929000
Accounts Payable:34614000
Total Short-Term Liabilities:77844000
Total Liabilities:105555000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
BOREL JAMES C   Director
6,500 sh at $23
$147,529
Buy
Green Ronald D   Director
1,500 sh at $23
$33,750
Buy
ADENT JOHN EDWARD   President & CEO
17,500 sh at $23
$403,725
Buy
Tobin James P   Director
2,000 sh at $23
$45,960
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
11,697,242 sh
47,806 sh
0%
$360,742
-$168,259
Vanguard Group Inc
10,467,026 sh
-117,085 sh
-1%
$322,802
-$157,822
Wasatch Advisors Inc
6,781,995 sh
-200,956 sh
-3%
$209,157
-$107,939
Conestoga Capital Advisors, LLC
3,875,795 sh
83,779 sh
2%
$119,530
-$52,665
Riverbridge Partners LLC
2,933,104 sh
79,715 sh
3%
$90,457
-$39,115
Neuberger Berman Group LLC
2,830,863 sh
184,898 sh
7%
$86,856
-$32,365
Geode Capital Management, LLC
1,995,280 sh
-17,855 sh
-1%
$61,534
-$29,916
Dimensional Fund Advisors LP
1,753,779 sh
25,158 sh
1%
$54,088
-$24,410
Bamco Inc /Ny/
1,712,583 sh
26,766 sh
2%
$52,816
-$23,737
JPMorgan Chase & Co
1,702,924 sh
137,459 sh
9%
$52,518
-$18,570
Northern Trust Corp
1,633,810 sh
-67,778 sh
-4%
$50,387
-$26,882
Geneva Capital Management LLC
1,576,160 sh
-21,180 sh
-1%
$48,609
-$23,925
King Luther Capital Management Corp
1,453,095 sh
1,250 sh
0%
$44,813
-$21,115
New York State Common Retirement Fund
1,409,672 sh
-51,736 sh
-4%
$43,474
-$22,889
Stephens Investment Management Group LLC
1,234,553 sh
11,595 sh
1%
$38,074
-$17,461
Bank Of New York Mellon Corp
1,144,360 sh
-17,434 sh
-2%
$35,292
-$17,464
Ranger Investment Management, L.P.
965,260 sh
24,980 sh
3%
$29,769
-$12,929
Allianz Asset Management Gmbh
918,694 sh
918,694 sh
NEW
$28,332
$28,332
Charles Schwab Investment Management Inc
870,329 sh
31,405 sh
4%
$26,841
-$11,255
Beacon Investment Advisory Services, Inc.
556,816 sh
-31,021 sh
-5%
$17,172
-$9,522
COMPANY PROFILE
1.
Summary of Significant Accounting Policies

Nature of Operations

Neogen Corporation develops, manufactures and markets a diverse line of products and services dedicated to food and animal safety.

Basis of Consolidation

The consolidated financial statements include the accounts of Neogen Corporation and its subsidiaries, all of which are wholly-owned as of May 31, 2021.

All intercompany accounts and transactions have been eliminated in consolidation.

Share and per share amounts reflect the June

4

, 2021 2-for-1 stock split as if it took place at the beginning of the periods presented.

Functional Currency

Our functional currency is the U.S. dollar. We translate our non-U.S.

operations’ assets and liabilities denominated in foreign currencies into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in other comprehensive income (loss). Gains or losses from foreign currency transactions are included in other income (expense) on our consolidated statement of income.

Recently Adopted Accounting Standards

Financial Instruments—Credit Losses

On June 1, 2020, the Company adopted ASU No. 2016-13—Measurement

of Credit Losses on Financial Instruments, which changes how the Company measures credit losses on most financial instruments measured at amortized cost and certain other instruments, such as loans, receivables and held-to-maturity

debt securities. Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires the Company to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the Company expects to collect over the instrument’s contractual life. The adoption of this guidance did not have a material impact on our consolidated financial statements due to the Company’s short-term contractual life of receivables and minimal expected losses.

Fair Value Measurements

On June 1, 2020, the Company adopted ASU 2018-13,

Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements of fair value measurements. The adoption of this guidance did not have an impact on our consolidated financial statements.

Cloud Computing Implementation Cost

On June 1, 2020, the Company adopted ASU 2018-15,

Intangible-Goodwill and Other Internal-Use

Software (Subtopic 350-40):

Customer’s Accounting for Implementation Cost Incurred in a Cloud Computing Arrangement That Is a Service Contract, which clarifies the accounting for implementation costs in cloud computing arrangements. The adoption of this guidance did not have an impact on our consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

Reference Rate Reform

In March 2020, FASB issued Update 2020-04,

Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This update provides temporary optional expedients to applying the reference rate reform guidance to contracts that reference LIBOR or another reference rate expected to be discontinued. Under this update, contract modifications resulting in a new reference rate may be accounted for as a continuation of the existing contract. This guidance is effective upon issuance of the update and applies to contract modifications made through December 31, 2022. We will adopt this standard when LIBOR is discontinued. We are evaluating the impact the new standard will have on our consolidated financial statements and related disclosures but do not anticipate a material impact.

Income Tax Simplification

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Update 2019-12,

Income Taxes (“To

Data imported from Neogen Corp SEC filings. Check original filings before making any investment decision.